產(chǎn)品詳情
簡單介紹：
Anti-SPATA15/SPATC1抗體產(chǎn)品質(zhì)量穩(wěn)定，實驗效果明顯，貨期快，價格優(yōu)惠，歡迎垂詢訂購！我公司長期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗所需全部相關(guān)試劑、熒光標記抗體、單克隆抗體、多克隆抗體、各種標記的二抗IgG/IgM/IgD/IgA等科研實驗抗體。Anti-SPATA15/SPATC1抗體用于**組化實驗,WB實驗,相應(yīng)的標記抗體有HRP標記抗體,FITC標記,BIO等。
詳情介紹：
Rabbit Anti-SPATA15/SPATC1
Cat. Number:
Anti-SPATA15/SPATC1抗體KL-17636R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
SPATA15 is a 591 amino acid cytoplasmic protein expressed in testis that is part of a complex that includes p55 CDC, Cdc27. The gene encoding Speriolin is located on human chromosome 8, which consists of nearly 146 million base pairs, houses more than 800 genes and is associated with a variety of diseases andAnti-SPATA15/SPATC1抗體 malignancies. Schizophrenia, bipolar disorder, Trisomy 8, Pfeiffer syndrome, congenital hypothyroidism, Waardenburg syndrome and some leukemias and lymphomas are thought to occur as a result of defects in specific genes that map to chromosome 8.
Also known as:
1700084J23Rik; MGC144830; MGC61633; SPATA15; Spatc1; SPERI_HUMAN; Speriolin; Spermatogenesis and Anti-SPATA15/SPATC1抗體centriole associated 1; Spermatogenesis and centriole-associated protein 1; Spermatogenesis-associated protein 15; Spermatogenic cell specific Cdc20 binding protein; Spermatogenic cell-specific Cdc20-binding protein.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Cow, Horse, Rabbit, Sheep, .
●
Immunogen: KLH conjugatedAnti-SPATA15/SPATC1抗體 synthetic peptide derived from human SPATA15/SPATC1.
●
Predicted Molecular Weight: 62kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500 Anti-SPATA15/SPATC1抗體
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
